Clinical Trial Update: Safety Study of Once a Day ART and Opiate Substitute. [Phase 4]

View source ↗

Summary

Phase 4 safety trial update for once-daily ART and an opiate substitute; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Once a Day ART
• Opiate Substitute

Snippet

Sponsor: Gilead Sciences | Conditions: HIV Infections | Phase 4 | Status: COMPLETED